ABVC BioPharma Inc
ABVC
|
News
|
$1.015
-9.38%
-10.34%
1.8M
|
Wholesale Trade
(0.0% 1d) (-10.5% 1m) (54.5% 1y) (0.0% 2d) (-8.9% 3d) (-6.4% 7d) (1458.38% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 10,718,827
https://abvcpharma.com
Sec Filling | Patents | 34 employees
ABVC BioPharma is a clinical-stage biopharmaceutical company focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions (such as Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center). The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development.
adhd
add to watch list Paper trade email alert is off
Press-releases
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: 2.68%
H: 3.48%
C: -11.3%
treatment biopharma royalties global for agreement
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: 5.74%
H: 1.55%
C: -11.63%
biopharma royalties global for
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: 33.81%
H: 3.2%
C: -8.9%
vitargus biopharma royalties global deal
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -0.54%
H: 3.33%
C: -1.32%
million biopharma
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -1.72%
H: 0.0%
C: 0.0%
ceo asia
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Published: 2024-03-14 (Crawled : 13:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -0.81%
H: 0.0%
C: 0.0%
first business year update biopharma
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: 0.82%
H: 0.0%
C: 0.0%
cancer market
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Published: 2024-02-15 (Crawled : 13:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -0.4%
H: 0.0%
C: 0.0%
license biopharma royalties agreement
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
Published: 2024-02-12 (Crawled : 13:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -0.76%
H: 3.05%
C: 2.29%
treatment biopharma
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
Published: 2024-02-08 (Crawled : 14:30) - globenewswire.com
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: -0.71%
H: 3.6%
C: -6.47%
million asia
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10